Received 21 June 2002/Returned for modification 23 July 2002/Accepted 24 September 2002
|
|
- Shannon Price
- 5 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2002, p Vol. 40, No /02/$ DOI: /JCM Copyright 2002, American Society for Microbiology. All Rights Reserved. Comparison of a Repetitive Extragenic Palindromic Sequence-Based PCR Method and Clinical and Microbiological Methods for Determining Strain Sources in Cases of Nosocomial Acinetobacter baumannii Bacteremia David Martín-Lozano, 1 * José Miguel Cisneros, 1 Berta Becerril, 2 Lucila Cuberos, 2 Trinidad Prados, 2 Carlos Ortíz-Leyba, 3 Elías Cañas, 1 and Jerónimo Pachón 1 Infectious Diseases Service 1, Microbiology Service, 2 and Intensive Care Unit, 3 Virgen del Rocío University Hospitals, Seville, Spain Received 21 June 2002/Returned for modification 23 July 2002/Accepted 24 September 2002 Using a repetitive extragenic palindromic PCR (REP-PCR), we genotypically characterized strains causing nosocomial Acinetobacter baumannii infections and analyzed the source of bacteremia in 67 patients from an institution in which infections by this bacterium were endemic. Six different genotypes were found, including 21, 27, 3, 9, 3, and 4 strains. The probable source of bacteremia, according to clinical and/or microbiological criteria, was known in 42 patients (63%): respiratory tract (n 19), surgical sites (n 12), intravascular catheters (n 5), burns (n 3), and urinary tract (n 3). The definite source of bacteremia, according to REP- PCR, could be established in 30 (71%) out of the 42 patients with strains from blood and other sites; in these cases clinical and microbiological criteria for the source of bacteremia were thus confirmed. In the remaining 12 patients (29%) the probable source was refuted by the REP-PCR method. The definite sources of bacteremia according to genotype were as follows: respiratory tract in 13 patients (31%), surgical sites in 8 (19%), intravascular catheters in 4 (9%), burns in 3 (7%), and urinary tract in 2 (5%). A comparison of strains from blood cultures and other sites with regard to their REP-PCR and antimicrobial resistance profiles was also made. Taking the REP-PCR as the gold standard, the positive predictive value of antibiotype was 77% and the negative predictive value was 42%. In summary, the utility of the diagnosis of the source of nosocomial A. baumannii bacteremia using clinical and/or microbiological criteria, including antibiotyping, is limited, as demonstrated by REP-PCR. Downloaded from Acinetobacter baumannii has been reported with increasing frequency as a significant pathogen involved in outbreaks of nosocomial infection. A. baumannii may cause a great number of clinical conditions, including pneumonia, bacteremia, urinary tract infections, wound infections, endocarditis, and meningitis. Treatment can be complicated by emergence of isolates with multiple-drug resistance (2, 5). The characteristics of A. baumannii bacteremia are widely described in the literature (2, 5, 21, 22, 26). The source of bacteremia is of epidemiological and prognostic interest (5, 21, 22, 26). According to recent studies, the source of A. baumannii bacteremia is unknown in 43 to 50% of the cases and, when the source can be established, the primary focus of infection is the respiratory tract, followed by intravascular catheters (5, 21, 22, 26). The diagnosis of the source of bacteremia is established by assessing clinical and, whenever possible, microbiological data. However, this method may not be completely appropriate in hospitals in which infections by A. baumannii are endemic, where the patients with bacteremia may be colonized by several different strains. In these cases, additional studies are necessary to determine the strain responsible for the infection. Methods such as antibiotyping have been used by different authors (6, 8, 24), but it seems to be poorly discriminatory for epidemiological purposes (9, 10, 13, 18, 22). The usefulness of molecular techniques has already been demonstrated in epidemiological studies of infections due to A. baumannii. The DNA restriction fragment length polymorphism analysis determined by pulsed-field gel electrophoresis is considered the gold standard method (19, 20) but is complex to perform, requires a considerable amount of time, and uses expensive reagents. Contrary to this method, several authors (3, 4) have shown that repetitive extragenic palindromic PCR (REP-PCR) is a simple, rapid, and relatively low-cost method, useful in the characterization of nosocomial outbreaks of A. baumannii infections, being comparable to pulsed-field gel electrophoresis in regard to discriminatory power and reproducibility. Moreover, REP-PCR has a higher power of discrimination and reproducibility than do other PCR-based fingerprinting systems (3, 11, 17, 23, 25). In the present work we carried out a genotype study of A. baumannii strains, isolated from bacteremic patients, using REP-PCR, with two objectives: first, to know the clonal distribution of bacteremia, and second, to compare the results obtained with the conventional clinical and/or microbiological diagnosis to those from the molecular identification. on November 18, 2018 by guest * Corresponding author. Mailing address: Servicio de Enfermedades Infecciosas, Hospitales Universitarios Virgen del Rocío, Avda. Manuel Siurot s/n, 41013, Seville, Spain. Phone: Fax: jpachon@hvr.sas.junta-andalucia.es. MATERIALS AND METHODS Setting. The Virgen del Rocío University Hospitals, Seville, Spain, is a 1,700- bed tertiary and teaching center. Approximately 58,000 patients are admitted each year, and there are two adult intensive care units (ICU), a severe-burn unit, and an active program of solid-organ and bone marrow transplantation. 4571
2 4572 MARTÍN-LOZANO ET AL. J. CLIN. MICROBIOL. Population study. The study was carried out using the strains isolated from the case patients of a prospective case control study designed to assess the attributable mortality of nosocomial A. baumannii bacteremia (J. M. Cisneros, D. Martín, B. Becerril, et al., Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother., abstr. K-1713, 2000), during the period from April 1997 to March Only true A. baumannii bacteremia were included, defined as an episode of bacteremia in a patient with clinical evidence of infection. The following data from each patient with A. baumannii bacteremia were recorded: gender, age, hospitalization ward (ICU, medical or surgical), nosocomial procedures (intravascular catheter, urinary tract catheter, mechanical ventilation, surgery, nasogastric tube, parenteral nutrition, and antimicrobial treatment), and score of Acute Physiology and Chronic Health Evaluation II (14). All cases were monitored until the death of the patient or discharge from the hospital. Nosocomial acquisition and the probable source of bacteremia were defined by standard clinical and microbiological criteria (7, 12). All data refer to the first episode of A. baumannii bacteremia in each patient. Microbiological and genotypic study. Blood cultures were requested by the physician in charge of each patient and processed using the BACTEC NR-860 system (Becton Dickinson, Cockeysville, Md.). When available, samples from the probable source of bacteremia were collected. Identification of A. baumannii was carried out using MicroScan (Baxter H.C., West Sacramento, Calif.), the API 20NE System (Bio-Mérieux, Marcy l Etoile, France), and the temperature growth test (44 C). Susceptibility to antimicrobial agents (ampicillin, ampicillinsulbactam, aztreonam, imipenem, cefotaxime, ceftazidime, gentamicin, amikacin, tetracycline, ciprofloxacin, and trimethoprim-sulfamethoxazole) was determined using the MicroScan system (Neg Breakpoint Combo Panel 2I) and the E test for colistin, following the criteria from the National Committee for Clinical Laboratory Standards (15). A. baumannii isolates were stored at 80 C in brucella broth containing 20% glycerol. The genotypic study was developed as described by other authors, using whole cells (23). Briefly, strains were grown on blood agar plates and were incubated overnight at 37 C to isolate single colonies. After incubation, four or five discrete colonies of each strain were resuspended in 50 l of sterile distilled water in a 0.5-ml Eppendorf tube. To lyse the cells and extract DNA, the tubes were heated for 10 min at 95 C, were then cooled on ice, and were centrifuged in a microcentrifuge (Microfuge Lite; Beckman) at 6,000 rpm for 60 s to remove the cell debris. These crude DNA extracts were kept on ice for immediate use. Portions (5 l) of these extracts were used in 50- l PCR mixtures without further purification. REP-PCR, which uses consensus primers for the REP sequences found in many bacterial chromosomes, was used in the genotyping of A. baumannii clones (23). This highly conserved REP sequence is approximately 35 nucleotides long, includes an inverted repeat, and can occur in the genome singly or as multiple adjacent copies. The primer pair REP 1 (5 -IIIGCGCCGICATCAGGC-3 ) and REP2(5 -ACGTCTTATCAGGCCTAC-3 ) was used to amplify putative REPlike elements in the bacterial DNA. Amplification PCRs were performed as described previously (23). A negative control to detect reagent contamination was included in each PCR, containing all components except the DNA extract, which was replaced by 5 l of sterile distilled H 2 O. Aliquots (12 l) of each sample were subjected to electrophoresis in a 1.5% agarose gel. Amplified products were detected by being stained with ethidium bromide and photographed with Polaroid type 665 film. In order to group isolates for photographic documentation, the REP-PCR fingerprints of strains were exposed to UV light, photographed, and compared by visual inspection. The molecular sizes of fragments generated by electrophoresis were judged by comparison with concurrently run molecular weight standards. Fingerprints were considered to be highly similar when all visible bands from two isolates had the same apparent migration distance. Variations in the intensity or shape of bands were not taken into account. The absence of up to two bands from a fingerprint was allowed, when all other visible bands in the fingerprints matched, before isolates were considered different by visual inspection (17, 23). Each isolate was run in duplicate. Fingerprint profiles were interpreted without knowledge of the clinical data. A source of bacteremia was considered definite when the strain from the probable source of bacteremia had the same REP-PCR genotype as the bacteremic strain. Statistical analyses. Results were expressed as mean standard deviation, median, and range or as a proportion of the total number of patients. The Fisher exact test was used. All statistical analyses were carried out by using Statistical Package for the Social Sciences software (version 10.0; Statistical Package for the Social Sciences Inc., Chicago, Ill.). TABLE 1. Antimicrobial susceptibility of A. baumannii strains Antimicrobial agent Breakpoint(s) ( g/ml) b RESULTS % of strains found to be: Susceptible Intermediate Resistant Ampicillin Ampicillin-sulbactam a 8/ Aztreonam Imipenem Cefotaxime Ceftazidime Gentamicin Amikacin Tetracycline Ciprofloxacin Trimethoprimsulfamethoxazole 2/ Colistin a The values for ampicillin-sulbactam apply to only 80 strains. b Where two breakpoints are listed, they are those of the individual drugs in the combination. Clinical characteristics of patients. From April 1997 to March 1999, 67 patients (41 males and 26 females) with true A. baumannii bacteremia were included, which represented an incidence of 0.54 episodes/1,000 admissions. Patients had a mean age of 52.2 years (range, 12 to 85 years). Fifty-one (76%) were in the ICU (44 in the general ICU, 5 in the burn unit, and 2 in the transplantation unit), 11 (16.5%) were in medical wards, and 5 (7.5%) were in surgical wards. Sixty-six (98.5%) patients had intravascular catheters, 63 (94%) had urinary catheters, 61 (91%) had received antimicrobial treatment for a median of 9 days (range, 0 to 16 days), 45 (67%) had mechanical ventilation, and 27 (40%) had undergone surgical procedures. The median interval between hospital admission and the onset of bacteremia was 13 days (range, 0 to 228). The mean Acute Physiology and Chronic Health Evaluation II score was Bacteremia was polymicrobial in 16 (24%) of the 67 patients. Staphylococcus epidermidis (37.5%) and Enterococcus faecalis (31%) were the most frequent concomitant isolates. There were severe sepsis in 26 cases (39%) and septic shock in 13 (19%). Twenty-six (38.8%) of the 67 cases died in the 30 days after the diagnosis of bacteremia. In surviving patients, the median hospital stay was 37 days (range, 3 to 144 days). Susceptibility testing. Table 1 details the percentage of resistant isolates among 109 A. baumannii isolates (67 from blood cultures and 42 from probable sources of bacteremia). Twenty-two isolates (20%) were resistant to all classes of antimicrobial agents tested except for colistin. Conversely, only four strains (4%) were susceptible to all classes of drugs. Genotyping. Isolates from blood cultures in the 67 patients were grouped according to the REP-PCR fingerprints in six different genotypes, named clones I to VI, which included 21 (31.5%), 27 (40%), 3 (4.5%), 9 (13.5%), 3 (4.5%), and 4 (6%) strains, respectively. Most of these clones were distributed throughout the study period with the exception of clone V, which appeared only during the first 6 months of the study (Fig. 1). Source of bacteremia. In the 67 patients, according to the standard clinical and/or microbiological criteria, the source of
3 VOL. 40, 2002 REP-PCR AND SOURCES OF A. BAUMANNII BACTEREMIA 4573 TABLE 3. Confirmation by REP-PCR of source of bacteremia established by clinical and/or microbiological criteria No. of cases for which source was: Source Probable, according to clinical and/or microbiological criteria Definite, according to REP-PCR (%) Refuted by REP-PCR (%) FIG. 1. Distribution of clones (I to VI) throughout the study period grouped by quarters. Respiratory tract (68) 6 (32) Surgical sites 12 8 (67) 4 (33) Intravascular catheters 5 4 (80) 1 (20) Burns 3 3 (100) 0 Urinary tract 3 2 (67) 1 (33) Total (71) 12 (29) bacteremia had a known origin in 42 patients (63%) (Table 2). Strains isolated from the probable source of bacteremia were available in these 42 patients. The distribution of sources was the following: respiratory tract (n 19), surgical sites (n 12), intravascular catheters (n 5), burns (n 3), and urinary tract (n 3). According to REP-PCR genotypes, the definite source of bacteremia could be established in 30 out of the 42 patients (71%), whereas, in the remaining 12 patients (29%) the strains from blood cultures and other sites showed different genotypes, the probable source being refuted by this method. Figure 2 shows fingerprints of representative strains of the six genotypes, both from blood and definite source strains. The definite sources of bacteremia according to genotype were as follows: respiratory tract in 13 patients (31%), surgical sites in 8 (19%), intravascular catheters in 4 (9%), burns in 3 (7%), and urinary tract in 2 patients (5%) (Table 3). The distribution of clones by the definite sources of bacteremia is shown in Table 4. A comparison of strains from blood cultures and other sites with regard to their REP-PCR and antimicrobial resistance profiles was also made to assess the usefulness of the antibiotype for epidemiological purposes. The strains were considered to have different antibiotypes when differences in susceptibility to two or more antimicrobial agents were observed (18, 22). In the 30 cases with the same genotype in blood and the definite source of bacteremia, 23 (77%) had the same antibiotype and 7 (23%) had different antibiotypes. In the 12 cases with different genotypes in blood and the probable source of bacteremia, 7 (58%) had the same antibiotype and 5 (42%) had different ones. Therefore, when REP-PCR was taken as the gold standard for the comparison of samples, the positive predictive value of the antibiotype was 77% and the negative predictive value was 42%. The crude mortality rate of A. baumannii bacteremia at 30 days was 39%. With respect to genotypes, the mortality rate was as follows: for clone I, 11 of 21 (52%); for clone II, 7 of 27 (26%); for clone III, 1 of 3 (33%); for clone IV, 3 of 9 (33%); for clone V, 2 of 3 (67%); and for clone VI, 2 of 4 (50%); these differences were not significant. DISCUSSION The clinical characteristics of nosocomial A. baumannii bacteremia in this study were similar to those reported from our institution in 1993 (5), although the incidence has decreased from 1.8 episodes per 1,000 admissions in 1993 to 0.54 episodes during the period of this study. The A. baumannii bacteremia predominantly occurs in patients admitted to the ICU, with high frequency of underlying chronic disease, extended previous hospital stay, and multiple nosocomial procedures. In addition, A. baumannii bacteremia is frequently associated with severe sepsis and/or septic shock and the mortality rate at 30 days is near 40%, similar to that reported in other data (5, 21, 26). A. baumannii resistance to antimicrobials was greater than TABLE 2. Probable sources of 67 episodes of nosocomial A. baumannii bacteremia Probable source of bacteremia a No. of cases attributed % Of cases attributed Unknown Respiratory tract Surgical sites Intravascular catheters 5 7 Urinary tract 3 5 Burns 3 5 a In accordance with clinical and/or microbiological criteria. FIG. 2. Representative REP-PCR fingerprints of A. baumannii isolates from blood and definite bacteremia sources, corresponding to the different genotypes. Lane 1, lambda EcoRI-HindIII molecular size marker (Master Diagnostica, Granada, Spain); lanes 2 and 3, genotype I (strains from blood and respiratory tract, respectively); lanes 4 and 5, genotype II (strains from blood and intravascular catheter, respectively); lanes 6, genotype III (strain from blood); lanes 7 and 8, genotype IV (strains from blood and surgical site, respectively); lane 9, genotype V (strain from blood); lanes 10 and 11, genotype VI (strains from blood and burn, respectively); and lane 12, negative control. Note: this figure is a composite of lanes from different gels.
4 4574 MARTÍN-LOZANO ET AL. J. CLIN. MICROBIOL. TABLE 4. Distribution of the different clones by the definite sources of bacteremia Source I II No. of examples of: III IV V VI Respiratory tract Surgical sites Intravascular catheter Burn Urinary tract that reported in 1993 (5). So, the resistance rate to ampicillinsulbactam and imipenem has risen from 7 to 33% and from 19 to 34%, respectively. The nosocomial A. baumannii bacteremias in this study were polyclonal, six different genotypes having been identified, as occurs in situations where disease is endemic (4). On the contrary, epidemic outbreaks are mainly due to a single clone of A. baumannii (1, 4). The distribution of clones throughout the study period shows that in our institution there is an situation where disease is endemic, with additional, different, small outbreaks. The polyclonal character of A. baumannii explains why 29% of 42 patients with two A. baumannii isolates in different clinical samples had genotypically different A. baumannii strains. The present study determined the probable source of A. baumannii bacteremia in 63% of cases by using clinical and/or microbiological criteria. The respiratory tract was the most common source, followed by surgical sites, intravascular catheters, urinary tract, and burns. In other studies, the respiratory tract was also the most common source of A. baumannii bacteremia, ranging from 31 to 41% of the cases with a known source (5, 21), and surgical sites and intravascular catheters were the second and third most common sources of A. baumannii bacteremia, in 10 and 6% of the instances (5). In another study, intravascular catheters were the most frequent source of A. baumannii bacteremia, being the cause of 22% of the cases (26). This discrepancy in results probably reflects the different number of patients admitted to the ICU: 84% in the present study versus 69% in the work of Wisplinghoff et al. (26). Finally, the urinary tract and burns are rarely reported as the source of bacteremia. In this study, using a molecular method with REP-PCR, we have proven that the diagnosis of source of bacteremia using conventional clinical and/or microbiological criteria was not always accurate. So, in 29% of the cases the conventional diagnosis of the probable source of bacteremia was incorrect, notably 32% in the respiratory tract, 33% from surgical sites, and 20% from intravascular catheters. These results illustrate the limitations of conventional methods in diagnosing the source of A. baumannii bacteremia. The usefulness of antibiotyping for the diagnosis of the source of A. baumannii bacteremia was limited, with a positive predictive value of 77% and negative predictive value of 42%. These results of antibiotyping should be interpreted with precaution because of the discrepancies of automated methods, such as MicroScan, with the standard broth dilution. However, in a study using 200 strains of gram-negative bacilli, when MicroScan was compared to broth dilution, in the 1,600 organism-antimicrobial combinations agreement occurred in 92%; moreover, the five discrepancies found with MicroScan were with Pseudomonas spp. and Providencia stuartii and in no case occurred when Acinetobacter calcoaceticus was being tested (16). These results confirm the low discrimination power of antibiotyping in comparison of different isolates, as has been reported in other epidemiological studies (9, 10, 13, 18, 22). In conclusion, the diagnosis of the source of nosocomial A. baumannii bacteremia by use of conventional clinical and/or microbiological criteria, including antibiotyping, is of limited utility, as demonstrated by REP-PCR. Additionally, the most common definite source of nosocomial A. baumannii bacteremia is the respiratory tract, followed by surgical sites and intravascular catheters. ACKNOWLEDGMENT This work was supported in part by a research grant from Consejería de Salud, Andalucía, Spain. REFERENCES 1. Beck-Sagué, C. M., W. R. Jarvis, J. H. Brook, D. H. Culver, A. Potts, E. Gay, B. W. Shotts, B. Hill, R. L. Anderson, and M. P. Weinstein Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am. J. Epidemiol. 132: Bergogne-Bérézin, E., and K. J. Towner Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9: Bou, G., G. Cerveró, M. A. Domínguez, C. Quereda, and J. Martínez-Beltrán PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin. Microbiol. Infect. 6: Bou, G., G. Cerveró, M. A. Domínguez, C. Quereda, and J. Martínez-Beltrán Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of -lactamases. J. Clin. Microbiol. 38: Cisneros, J. M., M. J. Reyes, J. Pachón, B. Becerril, F. J. Caballero, J. L. García-Garmendia, C. Ortiz, and A. R. Cobacho Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin. Infect. Dis. 22: Dijkshoorn, L., H. M. Aucken, P. Gerner-Smidt, M. E. Kaufmann, J. Ursing, and T. L. Pitt Correlation of typing methods for Acinetobacter isolates from hospital outbreaks. J. Clin. Microbiol. 31: Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes CDC definitions for nosocomial infections. Am. J. Infect. Control 16: Gerner-Smidt, P., and W. Frederiksen Acinetobacter in Denmark: I. Taxonomy, antibiotic susceptibility, and pathogenicity of 112 clinical strains. Acta Pathol. Microbiol. Immunol. Scand. 101: Gerner-Smidt, P., and I. Tjernberg Acinetobacter in Denmark: II. Molecular studies of the Acinetobacter calcoaceticus-acinetobacter baumannii complex. Acta Pathol. Microbiol. Immunol. Scand. 101: Gerner-Smidt, P., I. Tjernberg, and J. Ursing Reliability of phenotypic tests for identification of Acinetobacter species. J. Clin. Microbiol. 29: Grundmann, H. J., K. J. Towner, L. Dijkshoorn, P. Gerner-Smidt, M. Maher, H. Seifert, and M. Vaneechoutte Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCRbased fingerprinting of Acinetobacter spp. J. Clin. Microbiol. 35: Horan, T. C., R. P. Gaynes, W. J. Martone, W. R. Jarvis, and T. G. Emori CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect. Control Hosp. Epidemiol. 13: Kämpfer, P., I. Tjernberg, and J. Ursing Numerical classification and identification of Acinetobacter genomic species. J. Appl. Bacteriol. 75: Knaus, W. A., E. A. Draper, D. P. Wagner, and J. E. Zimmerman APACHE-II: a severity of disease classification system. Crit. Care Med. 13: National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard. NCCLS document M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
5 VOL. 40, 2002 REP-PCR AND SOURCES OF A. BAUMANNII BACTEREMIA Peterson, E. M., K. D. Evans, J. T. Shigei, M. T. Pezzlo, and L. M. de la Maza Evaluation of four anti-microbic susceptibility testing systems for gram-negative bacilli. Am. J. Clin. Pathol. 86: Reboli, A. C., E. D. Houston, J. S. Monteforte, C. A. Wood, and R. J. Hamill Discrimination of epidemic and sporadic isolates of Acinetobacter baumannii by repetitive element PCR-mediated DNA fingerprinting. J. Clin. Microbiol. 32: Scerpella, E. G., A. R. Wanger, L. Armitage, P. Anderlini, and C. D. Ericsson Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: results of the case-control and molecular epidemiologic investigations. Infect. Control Hosp. Epidemiol. 16: Seifert, H., and P. Gerner-Smidt Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates. J. Clin. Microbiol. 33: Seifert, H., A. Schulze, R. Baginski, and G. Pulverer Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii. J. Clin. Microbiol. 32: Seifert, H., A. Strate, and G. Pulverer Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine 74: Siau, H., K. Y. Yuen, P. L. Ho, S. S. Wong, and P. C. Woo Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin. Infect. Dis. 28: Snelling, A. M., P. Gerner-Smidt, P. M. Hawkey, J. Heritage, P. Parnell, C. Porter, A. R. Bodenham, and T. Inglis Validation of use of whole-cell repetitive extragenic palindromic sequence-based PCR (REP-PCR) for typing strains belonging to the Acinetobacter calcoaceticus-acinetobacter baumannii complex and application of the method to the investigation of a hospital outbreak. J. Clin. Microbiol. 34: Traub, W. H., and M. Spohr Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii. A. haemolyticus, genospecies 3, and genospecies 6). Antimicrob. Agents Chemother. 33: Vila, J., M. A. Marcos, and M. T. Jiménez de Anta A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-a. baumannii complex. J. Med. Microbiol. 44: Wisplinghoff, H., M. B. Edmond, M. A. Pfaller, R. N. Jones, R. P. Wenzel, and H. Seifert Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin. Infect. Dis. 31: Downloaded from on November 18, 2018 by guest
ORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2005.01184.x Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection
More informationEnfermedades Infecciosas, Hospital Universitario Virgen Macarena, Sevilla, Spain
REVIEW Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment J. M. Cisneros 1 and J. Rodríguez-Baño 2 1 Servicio de Enfermedades Infecciosas, Hospital Universitario
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationInt.J.Curr.Microbiol.App.Sci (2017) 6(3):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104
More informationWhat does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh
What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh Disclosures Merck Research grant Clinical context of multiresistance Resistance to more classes of agents Less options
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More information(This work was presented in part at the 18th Annual Meeting of the Surgical Infection Society, 30 April to 2 May 1998, abstr. P18, p. 93.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1035 1040 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Nontraditional
More informationMDR Acinetobacter baumannii. Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta
MDR Acinetobacter baumannii Has the post antibiotic era arrived? Dr. Michael A. Borg Infection Control Dept Mater Dei Hospital Malta 1 The Armageddon recipe Transmissible organism with prolonged environmental
More informationAcinetobacter baumannii Infection and Colonization among Pediatric Patients at Chiang Mai University Hospital
Original Article Vol. 24 No. 2 Acinetobacter baumannii infection among pediatric patients;- Oberdorfer P & Oberdorfer P. 63 Acinetobacter baumannii Infection and Colonization among Pediatric Patients at
More informationAcinetobacter Outbreaks: Experience from a Neurosurgery Critical Care Unit. Jumoke Sule Consultant Microbiologist 19 May 2010
Acinetobacter Outbreaks: Experience from a Neurosurgery Critical Care Unit Jumoke Sule Consultant Microbiologist 19 May 2010 Epidemiology of Acinetobacter spp At least 32 different species Recovered from
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationDetection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran
Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD
More informationMolecular characterization of carbapenemase genes in Acinetobacter baumannii in China
Molecular characterization of carbapenemase genes in Acinetobacter baumannii in China F. Fang 1 *, S. Wang 2 *, Y.X. Dang 3, X. Wang 3 and G.Q. Yu 3 1 The CT Room, Nanyang City Center Hospital, Nanyang,
More informationOriginal Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):
Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S
More informationEndemic and Epidemic Acinetobacter Species in a University Hospital: an 8-Year Survey
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2009, p. 3593 3599 Vol. 47, No. 11 0095-1137/09/$12.00 doi:10.1128/jcm.00967-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Endemic and
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationAntibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units
NEW MICROBIOLOGICA, 34, 291-298, 2011 Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units Vladimíra Vojtová 1, Milan Kolář 2, Kristýna Hricová 2, Radek Uvízl 3, Jan Neiser
More informationDetection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4008-4014 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.415
More informationNosocomial Infections: What Are the Unmet Needs
Nosocomial Infections: What Are the Unmet Needs Jean Chastre, MD Service de Réanimation Médicale Hôpital Pitié-Salpêtrière, AP-HP, Université Pierre et Marie Curie, Paris 6, France www.reamedpitie.com
More informationAcinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.
Biomedical Research 12; 23 (4): 571-575 ISSN 97-938X Scientific Publishers of India Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia. Nazmul MHM, Jamal
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationMicrobiology Unit, Hua Hin Hospital, Prachuap Khiri Khan, Thailand
IDENTIFICATION AND CHARACTERIZATION OF CARBAPENEMASE GENES IN CLINICAL ISOLATES OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII FROM A GENERAL HOSPITAL IN THAILAND Wichai Santimaleeworagun 1, Anukul Thathong
More informationQuantitative real-time PCR for the detection of Acinetobacter. baumannii colonization in the hospital environment
JCM Accepts, published online ahead of print on 1 February 2012 J. Clin. Microbiol. doi:10.1128/jcm.06566-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 SHORT-FROM ARTICLE
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationMulti-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes
Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control Alison Holmes The organism and it s epidemiology Surveillance Control What is it? What is it? What is it? What is it? Acinetobacter :
More informationSepsis is the most common cause of death in
ADDRESSING ANTIMICROBIAL RESISTANCE IN THE INTENSIVE CARE UNIT * John P. Quinn, MD ABSTRACT Two of the more common strategies for optimizing antimicrobial therapy in the intensive care unit (ICU) are antibiotic
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationPCR detection of Leptospira in. stray cat and
PCR detection of Leptospira in 1 Department of Pathology, School of Veterinary Medicine, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran 2 Department of Microbiology, School of Veterinary
More informationORIGINAL ARTICLE /j x. Mallorca, Spain
ORIGINAL ARTICLE 10.1111/j.1469-0691.2005.01251.x Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit
More informationAcinetobacter Resistance in Turkish Tertiary Care Hospitals. Zeliha KOCAK TUFAN, MD, Assoc. Prof.
Acinetobacter Resistance in Turkish Tertiary Care Hospitals Zeliha KOCAK TUFAN, MD, Assoc. Prof. Acinetobacter Problem Countries that have reported hospital outbreaks of carbapenem-resistant Acinetobacter
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationOverview of Nosocomial Infections Caused by Gram-Negative Bacilli
HEALTHCARE EPIDEMIOLOGY Robert A. Weinstein, Section Editor INVITED ARTICLE Overview of Nosocomial Infections Caused by Gram-Negative Bacilli Robert Gaynes, Jonathan R. Edwards, and the National Nosocomial
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More information03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline
Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?
More informationSurveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,
Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at
More informationDoes Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?
Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs? John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control and
More informationSURVEILLANCE AND INFECTION CONTROL IN AN INTENSIVE CARE UNIT
Vol. 26 No. 3 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 1 SURVEILLANCE AND INFECTION CONTROL IN AN INTENSIVE CARE UNIT Giovanni Battista Orsi, MD; Massimiliano Raponi, MD; Cristiana Franchi, MD; Monica
More information4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES
CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial
More informationCo-transfer of bla NDM-5 and mcr-1 by an IncX3 X4 hybrid plasmid in Escherichia coli 4
SUPPLEMENTARY INFORMATION ARTICLE NUMBER: 16176 DOI: 10.1038/NMICROBIOL.2016.176 Co-transfer of bla NDM-5 and mcr-1 by an IncX3 X4 hybrid plasmid in Escherichia coli 4 5 6 7 8 9 10 11 12 13 14 15 16 17
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More informationOther Enterobacteriaceae
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 50: Other Enterobacteriaceae Author Kalisvar Marimuthu, MD Chapter Editor Michelle Doll, MD, MPH Topic Outline Topic outline - Key Issues Known
More informationA review on multidrug - resistant Acinetobacter baumannii
ISSN: 2319-7706 Volume 3 Number 2 (2014) pp. 9-13 http://www.ijcmas.com Review Article A review on multidrug - resistant Acinetobacter baumannii Pavani Gandham* Department of Microbiology, Apollo Institute
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationMulti-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version
Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED 2018 Printed copies must not be considered the definitive version DOCUMENT CONTROL POLICY NO. IC-122 Policy Group Infection Control
More informationRISK FACTORS AND CLINICAL OUTCOMES OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII BACTEREMIA AT A UNIVERSITY HOSPITAL IN THAILAND
RISK FACTORS AND CLINICAL OUTCOMES OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII BACTEREMIA AT A UNIVERSITY HOSPITAL IN THAILAND Siriluck Anunnatsiri 1 and Pantipa Tonsawan 2 1 Division of Infectious
More informationSource: Portland State University Population Research Center (
Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:
More informationNational Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2004, p. 4606 4610 Vol. 48, No. 12 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.12.4606 4610.2004 Copyright 2004, American Society for Microbiology. All Rights
More informationMicrobiology of War Wounds AUBMC Experience
Microbiology of War Wounds AUBMC Experience Abdul Rahman Bizri MD MSc Division of Infectious Diseases Department of Internal Medicine AUBMC Conflict Medicine Program - AUB Current Middle- East Geopolitical
More informationClinical Characteristics, Antimicrobial Susceptibilities, andoutcomesofpatientswithchryseobacterium indologenes Bacteremia in an Intensive Care Unit
Jpn. J. Infect. Dis., 64, 520-524, 2011 Short Communication Clinical Characteristics, Antimicrobial Susceptibilities, andoutcomesofpatientswithchryseobacterium indologenes Bacteremia in an Intensive Care
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationBacteria Recovered from Patients Admitted to a Deployed U.S. Military Hospital in Baghdad, Iraq
MILITARY MEDICINE, 171, 9:821, 2006 Bacteria Recovered from Patients Admitted to a Deployed U.S. Military Hospital in Baghdad, Iraq Guarantor: MAJ Clinton K. Murray, MC USA Contributors: Capt Heather C.
More informationAerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune
Original article Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune Patil P, Joshi S, Bharadwaj R. Department of Microbiology, B.J. Medical College, Pune, India. Corresponding
More informationGENERAL NOTES: 2016 site of infection type of organism location of the patient
GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered
More informationUCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients
Background/methods: UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients This guideline establishes evidence-based consensus standards for management
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationPreventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier
More informationComparative Clinical Evaluation of the T2Bacteria Panel versus Blood Culture for the Diagnosis of Bacteremia
Comparative Clinical Evaluation of the T2Bacteria Panel versus Blood Culture for the Diagnosis of Bacteremia MH Nguyen, W Pasculle, PG Pappas, G Alangaden, G Pankey, B Schmitt, M Weinstein, R Widen, D
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationPILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996
PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY
More informationSummary of unmet need guidance and statistical challenges
Summary of unmet need guidance and statistical challenges Daniel B. Rubin, PhD Statistical Reviewer Division of Biometrics IV Office of Biostatistics, CDER, FDA 1 Disclaimer This presentation reflects
More informationClonal Diversity of Nosocomial Epidemic Acinetobacter baumannii Strains Isolated in Spain
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 2011, p. 875 882 Vol. 49, No. 3 0095-1137/11/$12.00 doi:10.1128/jcm.01026-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Clonal Diversity
More informationMultidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan
MDRAB J Microbiol in Immunol pediatric patients Infect. 2007;40:406-410 Original Article Multidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan Po-Yang
More information1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection
Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationOriginal Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc.
Original Article Vol. 21 No.1 The optimum agent for ESBL screening and confirmatory tests:- Srisangkaew S & Vorachit M. 1 The Optimum Agent for Screening and Confirmatory Tests for Extended-Spectrum Beta-Lactamases
More informationHEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE
Universidade de São Paulo Departamento de Moléstias Infecciosas e Parasitárias HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE Anna S. Levin 4 main lines! Epidemiology of HAS and resistance!
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationJump Starting Antimicrobial Stewardship
Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing
More informationAntibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen
Antibiotic usage in nosocomial infections in hospitals Dr. Birgit Ross Hospital Hygiene University Hospital Essen Infection control in healthcare settings - Isolation - Hand Hygiene - Environmental Hygiene
More informationAn evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",
More informationMeropenem for all? Midge Asogan ICU Fellow (also ID AT)
Meropenem for all? Midge Asogan ICU Fellow (also ID AT) Infections Common reason for presentation to ICU Community acquired - vs nosocomial - new infection acquired within hospital environment Treatment
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationAntimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali,
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/88030.htm Antimicrobial Susceptibility Patterns of Salmonella Typhi From Kigali, Rwanda. Ashok
More informationEvaluating the Role of MRSA Nasal Swabs
Evaluating the Role of MRSA Nasal Swabs Josh Arnold, PharmD PGY1 Pharmacy Resident Pharmacy Grand Rounds February 28, 2017 2016 MFMER slide-1 Objectives Identify the pathophysiology of MRSA nasal colonization
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationEtiology of blood culture isolates among patients in a multidisciplinary teaching hospital in Kuala Lumpur
Etiology J Microbiol of blood Immunol culture Infect. isolates in a teaching hospital 2007;40:432-437 Etiology of blood culture isolates among patients in a multidisciplinary teaching hospital in Kuala
More informationAdequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial
BRIEF REPORT Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial Rodger D. MacArthur, 1 Mark Miller, 2 Timothy Albertson, 3 Edward Panacek, 3
More informationTesting for antimicrobial activity against multi-resistant Acinetobacter baumannii. For. Forbo Flooring B.V. Final Report. Work Carried Out By
Technical Report Testing for antimicrobial activity against multi-resistant Acinetobacter baumannii For Forbo Flooring B.V. Final Report Work Carried Out By A. Smith Group Leader Peter Collins PRA Ref:
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationPlease distribute a copy of this information to each provider in your organization.
HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to
More informationAntimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services
Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO
More informationDr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center,
Dr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center, Hospital Authority NDM-1, which stands for New Delhi Metallo-beta-lactamase-1
More informationAntimicrobial Susceptibility Profile of E. coli Isolates Causing Urosepsis: Single Centre Experience
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 05 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.705.298
More informationLack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
Infect Dis Ther (2014) 3:55 59 DOI 10.1007/s40121-014-0028-8 BRIEF REPORT Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
More informationDepartment of Clinical Microbiology, Nottingham University Hospitals NHS Trust, Queen s Medical Centre, Nottingham, UK
ORIGINAL ARTICLE 10.1111/j.1469-0691.2007.01911.x Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe K. J. Towner, K. Levi and M. Vlassiadi, on behalf of the ARPAC
More informationNew Drugs for Bad Bugs- Statewide Antibiogram
New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda
More informationEmerging antimicrobial resistance and clinical relevance of Acinetobacter isolates in a tertiary care hospital of rural area of Punjab, India
8 P a g e Emerging antimicrobial resistance and clinical relevance of Acinetobacter isolates in a tertiary care hospital of rural area of Punjab, India POONAM SHARMA 1, YOUSUF UL BASHIR 1, SARJIWAN KAUR
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More information21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review
(1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationGeorgios Meletis, Efstathios Oustas, Christina Botziori, Eleni Kakasi, Asimoula Koteli
New Microbiologica, 38, 417-421, 2015 Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin
More informationThe Search For Antibiotics BY: ASLEY, ELIANA, ISABELLA AND LUNISCHA BSC1005 LAB 4/18/2018
The Search For Antibiotics BY: ASLEY, ELIANA, ISABELLA AND LUNISCHA BSC1005 LAB 4/18/2018 The Need for New Antibiotics Antibiotic crisis An antibiotic is a chemical that kills bacteria. Since the 1980s,
More informationMRSA surveillance 2014: Poultry
Vicky Jasson MRSA surveillance 2014: Poultry 1. Introduction In the framework of the FASFC surveillance, a surveillance of MRSA in poultry has been executed in order to determine the prevalence and diversity
More informationAntimicrobial Susceptibility Patterns
Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationPresenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update
Emergence of invasive Carbapenem Resistant Enterobacteriaceae CRE infection at RCWMCH Ombeva Oliver Malande, Annerie du Plessis, Colleen Bamford, Brian Eley Presenter: Ombeva Malande Red Cross Children's
More information